Taken together, our findings demonstrated that the CREB1‐CENPE axis was responsible for stimulating the in vitro and in vivo progression of ccRCC, serving as a promising therapeutic target for ccRCC. Here, CENPE is linked to nonpapillary renal cell carcinoma.